Endometrial Stromal Sarcoma: Case Series with Emphasis on Gross Features

  • Gunjan Mangla
  • Preeti DiwakerEmail author
  • Priyanka Gogoi
Case Report


Endometrial stromal sarcomas (ESS) constitute around 10% of uterine sarcomas, but only 0.2% of all uterine malignancies. ESS usually present in the peri-menopausal age group, as compared to other uterine malignancies which are more common in postmenopausal women [1]. ESS are often clinically misdiagnosed as benign entities like uterine leiomyomas and are usually diagnosed postoperatively, after a histopathological examination of a hysterectomy or polypectomy specimen [2]. This calls for a repeat surgery for definitive management.

ESS are indolent tumours, but can often present with late recurrence and metastasis [3]. Differentiating endometrial stromal nodule (ESN) from ESS is of utmost importance from the management point of view and is done on the basis of myometrial and/or vascular invasion. The recognition of gross features that could lead to a suspicion of an endometrial stromal tumour versus a leiomyoma is of vital importance, so that extensive sampling can be...



  1. 1.
    Puliyath G, Nair MK (2012) Endometrial stromal sarcoma: a review of the literature. Indian J Med Paediatr Oncol 33(1):1–6CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Ashraf-Ganjoei T, Behtash N, Shariat M, Mosavi A (2006) Low grade endometrial stromal sarcoma of uterine corpus, a clinico-pathological and survey study in 14 cases. World J Surg Oncol 4:50CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Kruse AJ, Croce S, Kruitwagen RF, Riedl RG, Slangen BF, Van Gorp T, Van de Vijver KK (2014) Aggressive behavior and poor prognosis of endometrial stromal sarcomas with YWHAE-FAM22 rearrangement indicate the clinical importance to recognize this subset. Int J Gynecol Cancer 24(9):1616–1622CrossRefPubMedGoogle Scholar
  4. 4.
    Ali RH, Rouzbahman M (2015) Endometrial stromal tumours revisited: an update based on the 2014 WHO classification. J Clin Pathol 68:325–332CrossRefPubMedGoogle Scholar
  5. 5.
    Masand RP, Euscher ED, Deavers MT, Malpica A (2013) Endometrioid stromal sarcoma: a clinicopathologic study of 63 cases. Am J Surg Pathol 37(11):1635–1647CrossRefPubMedGoogle Scholar
  6. 6.
    Olivia E, Egger JF, Young RH (2014) Primary endometrioid stromal sarcoma of the ovary: a clinicopathologic study of 27 cases with morphologic and behavioural features similar to those of uterine low grade endometrial stromal sarcoma. Am J Surg Pathol 38:305–315CrossRefGoogle Scholar
  7. 7.
    Husseiny GE, Bareedy NA, Mourad WA, Mohamed G, Shoukri M, Subhi J (2002) Prognostic factors and treatment modalities in uterine sarcoma. Am J Clin Oncol 25:256–260CrossRefPubMedGoogle Scholar
  8. 8.
    Gadducci A, Cosio S, Romanini A, Genazzani AR (2008) The management of patients with uterine sarcomas: a debated clinical challenge. Crit Rev Oncol Haematol 65:129–142CrossRefGoogle Scholar
  9. 9.
    Feng W, Hua K, Malpica A, Zhou X, Baak JP (2013) Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough? Int J Gynecol Cancer 23(3):488–493CrossRefPubMedGoogle Scholar

Copyright information

© Indian Association of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Department of PathologyUniversity College of Medical Sciences & Guru Teg Bahadur HospitalDelhiIndia

Personalised recommendations